Showing 1 to 1 of 1 results
nbcnews.com
🌐 85% Global Worthiness
Immunotherapy Shows Promise in Treating Mismatch Repair Deficient Cancers
A clinical trial at Memorial Sloan Kettering showed that immunotherapy was highly effective in treating mismatch repair deficient (MMRd) cancers, potentially eliminating the need for surgery, chemotherapy, and radiation for many patients, significantly improving quality of life.
Immunotherapy Shows Promise in Treating Mismatch Repair Deficient Cancers
A clinical trial at Memorial Sloan Kettering showed that immunotherapy was highly effective in treating mismatch repair deficient (MMRd) cancers, potentially eliminating the need for surgery, chemotherapy, and radiation for many patients, significantly improving quality of life.
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results